Understanding the European Market
Understanding the European Market
The Challenge
A mid-sized pharmaceutical company was looking to enter the European market through a compassionate use/early access pathway but lacked an understanding of the requirements specific to each country that would lead to broad access and reimbursement for their product across Europe.
The IP Solution
To gain in-depth knowledge of the European market landscape as it related to compassionate use/early access, we employed our team of European experts to conduct primary and secondary market research.
With our deep understanding of the intricacies of the market in conjunction with our knowledge of the EMA and EU pharmaceutical legislation options, we developed a plan which outlining various pathways to early access across the EU5 and United Kingdom, including specific insights into marketing authorization pricing and reimbursement strategies for each country.
The Results
IP’s detailed strategy and recommendations enabled the company to provide patients across European Markets access to their product as quickly as possible.
